Jazz Pharmaceuticals (JAZZ) 10-K/A2022 FY Annual report (amended)

Filed: 1 May 23, 4:09pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Acceleron, acid, agonist, ahead, alpha, Altimmune, Alum, ambition, amide, Ann, Anne, Axsome, BC, BPOC, choice, chose, depth, dialogue, discontinue, divestiture, Dravet, East, EMA, Epidyolex, error, evidence, Exiting, falling, Fatty, felt, frequency, Germany, healthy, Heather, hereto, hydrolase, IM, inadvertent, inflection, interferon, interpolation, intramuscular, introduce, JML, Lifecore, linear, MAA, MAPK, margin, marital, MWF, paragraph, Parkinson, Peter, pledging, protein, PTSD, published, quantification, readout, real, Reform, restructuring, Rick, rulemaking, scenario, segment, South, Spain, speaking, Street, strength, strict, tolerability, traditionally, twenty, UCSF, Wall, zanidatamab

Removed: acute, adult, Aerial, AmCham, applying, Asian, asparaginase, attestation, backdrop, Bearing, Beecken, BioEclipse, budget, carried, category, chairman, challenging, childcare, client, commence, competing, credited, deal, defibrotide, demonstrated, Digital, disclosed, diversify, Doctor, England, entry, equitable, Exceeding, expansion, expired, fell, financing, flexible, focusing, French, hiring, improvement, inclusive, inherently, Issuer, Kline, Lender, leukemia, Licence, lieu, lreland, lymphoblastic, lymphoma, measurable, milestone, movement, Neuralstem, Novation, objectively, older, OPi, organizational, outperformance, Petty, Porton, prevention, qualitative, quantitative, ready, realizable, receiving, resigned, Royalty, scalability, Schnee, split, statute, successive, supplement, Swing, thoughtful, tied, UCB, unchanged, upfront, Variation, weighed

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated JAZZ transcripts

JAZZ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 31.3

CERTIFICATION

I, Bruce C. Cozadd, certify that:

I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Jazz Pharmaceuticals public limited company;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

Date: May 1, 2023

By:

/s/ Bruce C. Cozadd

Bruce C. Cozadd

Chairman, Chief Executive Officer and Director

(Principal Executive Officer)